These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 38414439)
1. Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies. Li DY; Liu X; Huang JY; Hang WL; Yu GR; Xu Y Ther Adv Respir Dis; 2024; 18():17534666241232561. PubMed ID: 38414439 [TBL] [Abstract][Full Text] [Related]
2. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases. Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637 [TBL] [Abstract][Full Text] [Related]
3. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases. Lamb YN Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296 [TBL] [Abstract][Full Text] [Related]
4. Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Petnak T; Lertjitbanjong P; Thongprayoon C; Moua T Chest; 2021 Nov; 160(5):1751-1763. PubMed ID: 34217681 [TBL] [Abstract][Full Text] [Related]
5. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib. Makino S Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766 [TBL] [Abstract][Full Text] [Related]
6. Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study. Joung KI; Park H; Park S; Shin JY; Kim YH BMC Pulm Med; 2023 Mar; 23(1):98. PubMed ID: 36949407 [TBL] [Abstract][Full Text] [Related]
7. [Use of antifibrotic drugs in interstitial lung disease]. Kreutz CP; Gesierich W; Behr J; Kneidinger N Dtsch Med Wochenschr; 2022 Oct; 147(21):1383-1390. PubMed ID: 36279864 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis. Finnerty JP; Ponnuswamy A; Dutta P; Abdelaziz A; Kamil H BMC Pulm Med; 2021 Dec; 21(1):411. PubMed ID: 34895203 [TBL] [Abstract][Full Text] [Related]
15. Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases. Cottin V; Richeldi L; Rosas I; Otaola M; Song JW; Tomassetti S; Wijsenbeek M; Schmitz M; Coeck C; Stowasser S; Schlenker-Herceg R; Kolb M; Respir Res; 2021 Mar; 22(1):84. PubMed ID: 33726766 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: A systematic review and meta-analysis. Yang M; Wu Y; Liu X; Zhao C; Li T; Li T; Zhang X; Jiang H; Mao B; Liu W Respir Med; 2023 Sep; 216():107329. PubMed ID: 37315742 [TBL] [Abstract][Full Text] [Related]
17. Antifibrotic drugs as treatment of nonidiopathic pulmonary fibrosis interstitial pneumonias: the time is now (?). Kreuter M; Wälscher J; Behr J Curr Opin Pulm Med; 2017 Sep; 23(5):418-425. PubMed ID: 28622199 [TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of the clinical benefits and adverse reactions of anti-fibrotics in non-IPF progressive fibrosing ILD. Chong WH; Agrawal D; Tan ZY; Venkateswaran S; Tan AYY; Tan CY; Ling NCA; Tay NSWT Heart Lung; 2024; 68():242-253. PubMed ID: 39089077 [TBL] [Abstract][Full Text] [Related]
19. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients. Feng H; Zhao Y; Li Z; Kang J Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705 [TBL] [Abstract][Full Text] [Related]
20. Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD. Shumar JN; Chandel A; King CS J Clin Med; 2021 May; 10(11):. PubMed ID: 34070297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]